Literature DB >> 21878606

Premature discard of proton pump inhibitors: possible osteoporosis vs enhanced gastrointestinal bleed, adenocarcinoma efficacy.

Aaron S Geller.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21878606      PMCID： PMC3257998          DOI： 10.4065/mcp.2011.0237

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN： 0025-6196            Impact factor:   7.616


× No keyword cloud information.
  5 in total

1.  Proton pump inhibitor use, hip fracture, and change in bone mineral density in postmenopausal women: results from the Women's Health Initiative.

Authors:  Shelly L Gray; Andrea Z LaCroix; Joseph Larson; John Robbins; Jane A Cauley; JoAnn E Manson; Zhao Chen
Journal:  Arch Intern Med       Date:  2010-05-10

Review 2.  Update on medications with adverse skeletal effects.

Authors:  Caroline J Davidge Pitts; Ann E Kearns
Journal:  Mayo Clin Proc       Date:  2011-03-09       Impact factor: 7.616

3.  Proton pump inhibitors and histamine-2 receptor antagonists are associated with hip fractures among at-risk patients.

Authors:  Douglas A Corley; Ai Kubo; Wei Zhao; Charles Quesenberry
Journal:  Gastroenterology       Date:  2010-03-27       Impact factor: 22.682

Review 4.  Management of NSAID-induced gastrointestinal toxicity: focus on proton pump inhibitors.

Authors:  Marco Lazzaroni; Gabriele Bianchi Porro
Journal:  Drugs       Date:  2009       Impact factor: 9.546

5.  Cost effectiveness of COX 2 selective inhibitors and traditional NSAIDs alone or in combination with a proton pump inhibitor for people with osteoarthritis.

Authors:  Nicholas Latimer; Joanne Lord; Robert L Grant; Rachel O'Mahony; John Dickson; Philip G Conaghan
Journal:  BMJ       Date:  2009-07-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.